Research Article

Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences

Table 1

Summary of baseline characteristics in relation to ethnicity. Data are presented as median (IQR) or mean ± 1SD depending on data distribution. The percentages represent % of participants in the ethnic group. STR: sight threatening retinopathy defined as preproliferative or proliferative retinopathy or maculopathy or previous laser treatment. TIA: transient ischaemic attack. PVD: peripheral vascular disease.

South Asians
()
White Caucasians
()
value

Age (years)0.003
Male (%)60.356.40.521
Smoking (current or ex-smoker)30.250.70.001
Alcohol (%)2.447.9<0.001
Diabetes duration (years)11.0 (7.0–18.0)10.5 (5.0–16.0)0.153
BMI (kg/m2)30.1 (26.5–33.6)35.3 (31.8–41.4)<0.001
Waist circumference (cm)103.2 (96.9–113.1)117.2 (109.2–129.4)<0.001
Hip circumference (cm)102.5 (97–112.25)120.0 (108.6–131.75)<0.001
Waist/hip ratio0.276
Neck circumference (cm)39.0 (36.9–41.8)43.0 (39.6–47.0)<0.001
Height (cm)0.051
Neck height ratio<0.001
Systolic blood pressure (mmHg)126.0 (115.5–138.5)130.0 (124.5–140.0)0.008
Diastolic blood pressure (mmHg)77.5 (70.0–84.5)79.0 (73.6–85.9)0.032
HbA1c (%)8.0 (7.16–9.20)8.0 (7.23–9.19)0.868
Total cholesterol (mmol/L)3.7 (3.3–4.3)3.7 (3.3–4.4)0.637
Triglycerides (mmol/L)1.8 (1.1–2.4)1.7 (1.3–2.5)0.550
HDL (mmol/L)1.1 (0.9–1.2)1.1 (0.9–1.3)0.217
TSH (mU/L)1.6 (1.0–2.3)1.9 (1.4–2.3)0.024
Estimated GFR (mL/min/1.73 m2)0.053
Oral antidiabetes agent (%)91.392.90.632
Sulphonylureas (%)42.130.70.054
Insulin (%)50.057.90.199
Insulin dose (units)80.0 (44.0–118)67.0 (52.0–97.5)0.649
GLP-1 analogues (%)4.017.10.001
Lipid lowering treatment (%)81850.379
Antihypertensive therapy74.684.30.05
Antiplatelet agents (%)65.664.50.847
Albuminuria (%)38.634.60.536
STR (%)36.036.80.908
Ischaemic heart disease (%)23.017.10.231
CABG (%)13.510.00.375
Stroke/ TIA (%)9.510.70.748
PVD (%)2.48.60.029